Instructions for Ibuclin Junior (Paracetamol, Ibuprofen) 20 pills
Release form
Tablets dispersed for children
Description Ibuclin:
The tablets are dispersed (for children) in pink with dyeing, flat-cylindrical, with chamfer and risk on one side, with a fruity-mint smell.
1 tab.
ibuprofen 100 mg
paracetamol 125 mg
Auxiliary substances:
cellulose microcrystalline - 20 mg,
cornstarch - 59.04 mg,
lactose - 5 mg,
sodium carboxymethyl starch (type A) - 30 mg
glycerol - 2 mg
silicon dioxide colloidal - 5 mg
powder dye (Ponso 4R) (E124) - 0.2 mg,
orange flavoring DC 100PH - 1.6 mg, aromatizator pineapple DC 106PH - 2.5 mg,
leaf oil You pepper - 0.66 mg,
aspartame - 10 mg,
magnesium stearate - 1 mg,
talc - 3 mg.
10 pcs - blister packs (1) complete with spoon for preparing suspension - cardboard packs.
10 pcs - blisters (2) complete with spoon for preparing suspension - cardboard packs.
10 pcs - blister packs (20) with a spoon for preparing the suspension - cardboard packs.
ATC codes
M01AE51 Ibuprofen in combination with other drugs
Clinical-pharmacological groups / Group affiliation Ibuclin
Analgesic-antipyretic combined composition
Active substance
ibuprofen
Paracetamol
Pharmacotherapy group Ibuclin
Analgesic non-arcotic agent (NSAID+non-arcotic analgesic)
Testimony:
- For adults:
- moderate-intensity pain syndrome; traumatic inflammation of the soft tissues and musculoskeletal system (including
- bruises,
- sprains,
- dislocations,
- fractures);
- post-operative period;
- algodismenorrhea;
- toothache;
- neuralgia;
- myalgia;
- lumbago;
- fibrositis;
- tendovaginite;
- headache;
- feverish syndrome;
- joint syndrome (rheumatoid arthritis,
- osteoarthrosis, ankylosing spondyloarthritis, podagric arthritis);
- sinusitis;
- tonsillitis.
For children (as an auxiliary drug): tonsillitis; acute infection-inflammatory diseases of upper respiratory tract (pharyngitis, tracheitis, laryngitis).
Method of use, course and dosage:
Inside. The dose, frequency and duration of use depend on the patient's indication, age.
Application for kidney disorders
It is contraindicated in kidney failure.
Use in liver disorders
It is contraindicated in liver failure.
Use in children
Use is contraindicated for children under 2 years of age.
Nosology (ICD codes)
J01
Acute sinusitis
J02
Acute pharyngitis
J03
Acute tonsillitis
J04
Acute laryngitis and tracheitis
J06.9
Acute upper respiratory tract infection unspecified
J32
Chronic sinusitis
J35.0
Chronic tonsillitis
K08.8
Other refined changes of teeth and their support apparatus (including toothache)
M05
Seropositive rheumatoid arthritis
M10
Podagra
M15
Polyarthrosis
M19.9
Arthrosis unspecified
M25.5
Joint pain
M42
Spinal osteochondrosis
M45
Ankylosing spondylitis
M47
Spondylosis
M54.1
Radikulopathy
M54.3
Ishias
M54.4
Lumbago with Sciatica
M65
Synovitis and tenosinovites
M70
Soft tissue diseases related to load, overload and pressure
M71
Other bursopathy
M79.1
Mialgia
M79.2
Neuralgia and Neuritis Unspecified
M79.7
Fibromyalgia (including fibromyositis, fibrositis)
N94.4
Primary dysmenorrhea
N94.5
Secondary dysmenorrhea
R07.0
Sore throat
R50
Fever of uncertain origin
R51
Headache
R52.0
Acute pain
R52.2
Other persistent pain (chronic)
T14.2
Fracture in unspecified body region
T14.3
Dislocation, stretching and overtension of the capsule-bonding apparatus of the unspecified body region joint
Pharmacological effect Paracetamol:
The combined drug comprises ibuprofen (NSAID) and Paracetamol (analgesic-antipyretic).
Ibuprofen has analgesic, anti-inflammatory, antipyretic and antipyretic effects.
Oppressive COX-1 and COX-2, disrupts peanut acid metabolism, reduces the number of prostaglandins (pain, inflammation and hyperthermal responses mediators), both in the center of inflammation and in healthy tissues, suppresses the exudative and proliferative phases of inflammation.